Jonathan Kolitz MD

Hematologic Oncology

Professor of Medicine Zucker School of Medicine at Hofstra/Northwell System Head, Leukemia R.J. Zuckerberg Cancer Institute Northwell Health System

Join to view full profile

450 Lakeville RoadLake Success, NY 11042
Phone+1 516-734-8970

Dr. Kolitz is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kolitz's full profile Already have an account?

Summary

Dr. Jonathan Kolitz is an oncologist in Lake Success, NY and is affiliated with multiple hospitals in the area, including Long Island Jewish Medical Center and North Shore University Hospital. He received his medical degree from Yale University School of Medicine and has been in practice 38 years. He specializes in hematologic oncology and is experienced in hematologic oncology, myeloproliferative disease, acute and chronic leukemias, and plasma cell dyscrasias.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1980 - 1982
Yale School of MedicineClass of 1979
Columbia UniversityBA, Summa cum Laude, 1975

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 1980 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2006-2018
CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2016-2017
CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2016-2017

Clinical Trials

Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
COMPLETED
PHASE1, PHASE2
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
COMPLETED
PHASE3
Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML
COMPLETED
PHASE2

Publications & Presentations

PubMed

Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia.
Darren Lee, Yazan Abu-Shihab, Kate Plas, Deedra Nicolet, Krzysztof Mrózek
Leukemia. 2026-08-01
1 citations
Characterization of the clonal hierarchy and immunophenotype of PTPN11 mutations in acute myeloid leukemia.
Sydney Fobare, Chia Sharpe, Kate Quinn, Kinsey Bryant, Linde A Miles
JCI Insight. 2026-02-23
1 citations
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid...
Monica Cusan, Karilyn Larkin, Deedra Nicolet, Vindi Jurinovic, Krzysztof Mrózek
Leukemia. 2025-12-01

Journal Articles

NF1 Mutations Are Recurrent in Adult Acute Myeloid Leukemia and Confer Poor Outcome
Eunice S Wang, Bayard L Powell, Richard M Stone, John C Byrd, Clara D Bloomfield, Alice Mims, Andrew J Carroll, Jonathan E Kolitz, James S Blachly, Nature
A complex variant Philadelphia chromosome translocation involving chromosomes no. 11, 14, and 22 in a case of chronic myelogenous leukemia.
Kolitz, J.E., Schulman, P., Kardon, N., Budman, D.R., Vinciguerra, V.P., Broekman, A. and Degnan, T.J, Cancer Genetics and Cytogenetics 1981; 4:185-188
Human Interleukin 2 gene is located on chromosome 4.
Sykora, K.W., Kolitz, J., Szabo, P., Grzeschik, K.H., Moore, M.A.S. and Mertelsmann, R, Cancer Investigation 1984; 2:261-265

Books/Book Chapters

Development, Testing, and Use of Biologically Active Substances in Cancer Therapy.
Chapter: Treatment of Cancer with Interleukin 2
Mertelsmann, R., Welte, K., Sykora, K.W., Kolitz, J., Holloway, K., Fiedler, W., Miller, G., Merluzzi, V., Venuta, S., Engert, A., Stein, C., Polivka, A., Levi, EEditors: Schuff-Werner P., Pfizenmaier, K.Zuckschwerdt Verlag, Munich
Cellular and Molecular Biology of Lymphokines.
Chapter: The role of interleukin 2 in human immunodeficiency states
Page 755 - 789Welte, K., Kolitz, J.E., Merluzzi, V.J., Flomenberg, N., Engert, A., Miller, G.A.,Holloway, K., Sykora, K.W., Venuta, S., Bradley, E., O’Reilly, R.J. Oettgen, H.F., Me...Editors: Sorg, C. and Schimpl, A.Academic Press, New York
Modern Trends in Human Leukemia, Vol. VII.
Chapter: Cytokines with possible clinical utility
Page 97 - 102Mertelsmann R., Kolitz, J., Welte, K., Herrmann, FEditors: Neth, R., Gallo, R.C.

Abstracts/Posters

Distinct Gene Expression Profiles and Mutations Associate with Outcome in Younger Adults with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (Alliance)
Jonathan E. Kolitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
CLL B Cells Develop Resistance to Ibrutinib By Reinvigorating the IL-4R - IL-4 Axis Blocked By BrutonÍs Tyrosine Kinase Inhibitors Including Acalabrutinib and Zanubrut...
Jonathan E. Kolitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Next-Generation RNA Sequencing-Based Analysis Identifies a Novel Set of Prognostic Micrornas (miRs) in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)
Jonathan E. Kolitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Phase 3 Exploratory Analysis of Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Received Consolidation with CPX-351 ...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Mutations in Genes Associated with Familial Predisposition to Myeloid Neoplasms: Their Frequency and Associations with Pretreatment Characteristics in Adult Patients (...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Musashi 2 Is Overexpressed in Poor Outcome CLL Patients and Their Proliferative Fraction and Silencing This Gene Induces Apoptosis and Increases Cell Adhesion and Move...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Interleukin 2 - Basic and Clinical Studies.
Kolitz, J.E., Mertelsmann, R., Welte, K, Cancer Bulletin (M.D. Anderson Hospital) 1987; 39:13-18
Acute leukemia in adults.
Kolitz, J.E, Dis. Month 2008: 54:226-241